TCL Archive Particle Therapy Program Would cost $600 million Over 10 Years for 16 Facilities, Clinical Trials December 2, 1977
TCL Archive IVAX Agreement With Rival BMS Appears To Buttress BMS control of Paclitaxel November 26, 1999
TCL Archive Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial December 25, 2009
TCL Archive DCT Survey Shatters Myth That Young Investigator Have Difficulty Getting Grants – They’re Doing Better Than Those Over Age 40 August 3, 1984
